These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22972545)

  • 21. Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and Activators.
    Zheng S; Hedl M; Abraham C
    J Immunol; 2015 Jul; 195(1):217-26. PubMed ID: 26019273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twist plays an essential role in FGF and SHH signal transduction during mouse limb development.
    O'Rourke MP; Soo K; Behringer RR; Hui CC; Tam PP
    Dev Biol; 2002 Aug; 248(1):143-56. PubMed ID: 12142027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The basic helix loop helix transcription factor Twist1 is a novel regulator of ATF4 in osteoblasts.
    Danciu TE; Li Y; Koh A; Xiao G; McCauley LK; Franceschi RT
    J Cell Biochem; 2012 Jan; 113(1):70-9. PubMed ID: 21866569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis.
    Aberg T; Wang XP; Kim JH; Yamashiro T; Bei M; Rice R; Ryoo HM; Thesleff I
    Dev Biol; 2004 Jun; 270(1):76-93. PubMed ID: 15136142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twist1-induced invadopodia formation promotes tumor metastasis.
    Eckert MA; Lwin TM; Chang AT; Kim J; Danis E; Ohno-Machado L; Yang J
    Cancer Cell; 2011 Mar; 19(3):372-86. PubMed ID: 21397860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium.
    Hinoi E; Bialek P; Chen YT; Rached MT; Groner Y; Behringer RR; Ornitz DM; Karsenty G
    Genes Dev; 2006 Nov; 20(21):2937-42. PubMed ID: 17050674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
    Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
    Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Runx2-Twist1 interaction coordinates cranial neural crest guidance of soft palate myogenesis.
    Han X; Feng J; Guo T; Loh YE; Yuan Y; Ho TV; Cho CK; Li J; Jing J; Janeckova E; He J; Pei F; Bi J; Song B; Chai Y
    Elife; 2021 Jan; 10():. PubMed ID: 33482080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction.
    Xu X; Weinstein M; Li C; Naski M; Cohen RI; Ornitz DM; Leder P; Deng C
    Development; 1998 Feb; 125(4):753-65. PubMed ID: 9435295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts.
    Teplyuk NM; Haupt LM; Ling L; Dombrowski C; Mun FK; Nathan SS; Lian JB; Stein JL; Stein GS; Cool SM; van Wijnen AJ
    J Cell Biochem; 2009 May; 107(1):144-54. PubMed ID: 19259985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of RUNX2 and its signaling partners TCF7, FGFR1/2 in cleidocranial dysplasia.
    Pawłowska E; Wójcik KA; Synowiec E; Szczepańska J; Błasiak J
    Acta Biochim Pol; 2015; 62(1):123-6. PubMed ID: 25738174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription.
    Neben CL; Idoni B; Salva JE; Tuzon CT; Rice JC; Krakow D; Merrill AE
    Hum Mol Genet; 2014 Nov; 23(21):5659-71. PubMed ID: 24908667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential configurations involving binding of USF transcription factors and Twist1 regulate Alx3 promoter activity in mesenchymal and pancreatic cells.
    García-Sanz P; Fernández-Pérez A; Vallejo M
    Biochem J; 2013 Feb; 450(1):199-208. PubMed ID: 23181698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor signaling regulates the expansion of A6-expressing hepatocytes in association with AKT-dependent β-catenin activation.
    Utley S; James D; Mavila N; Nguyen MV; Vendryes C; Salisbury SM; Phan J; Wang KS
    J Hepatol; 2014 May; 60(5):1002-9. PubMed ID: 24365171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta and Wnt signals regulate chondrocyte differentiation through Twist1 in a stage-specific manner.
    Dong YF; Soung do Y; Chang Y; Enomoto-Iwamoto M; Paris M; O'Keefe RJ; Schwarz EM; Drissi H
    Mol Endocrinol; 2007 Nov; 21(11):2805-20. PubMed ID: 17684115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 inhibits in-vitro mineral deposition by human periodontal ligament cells via modulating the expression of TWIST1 and RUNX2.
    Manokawinchoke J; Pimkhaokhum A; Everts V; Pavasant P
    J Periodontal Res; 2014 Dec; 49(6):777-84. PubMed ID: 24410709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch inhibits chondrogenic differentiation of mesenchymal progenitor cells by targeting Twist1.
    Tian Y; Xu Y; Fu Q; Chang M; Wang Y; Shang X; Wan C; Marymont JV; Dong Y
    Mol Cell Endocrinol; 2015 Mar; 403():30-8. PubMed ID: 25596548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.
    Wu F; Ye X; Wang P; Jung K; Wu C; Douglas D; Kneteman N; Bigras G; Ma Y; Lai R
    BMC Cancer; 2013 Jul; 13():317. PubMed ID: 23815808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target.
    Roberts CM; Shahin SA; Loeza J; Dellinger TH; Williams JC; Glackin CA
    BMC Cancer; 2017 Mar; 17(1):184. PubMed ID: 28283022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.